The PGY2 Oncology Pharmacy Residency Program at The University of Arizona Cancer Center/Banner – University Medical Center Tucson is a 12-month program for training residents with an interest in oncology, hematology, stem cell transplant, and investigational drug research. The program was established in 2016 and currently has one PGY2 oncology resident. This program is currently under pre-accreditation status by the American Society of Health-System Pharmacists (ASHP). Upon successful completion of the residency program, a certificate will be awarded to the resident by The University of Arizona College of Pharmacy, University of Arizona Cancer Center, and Banner – University Medical Center Tucson.
The PGY2 Oncology Pharmacy Residency provides a well-rounded experience in acute and ambulatory medical oncology, hematology, and stem cell transplant. The PGY2 oncology resident will be actively involved in the therapeutic decision-making process and clinical outcomes for cancer patients. In addition, the resident will gain experiences in teaching, precepting, clinical research, and quality improvement. The residency is designed to instill a philosophy that denotes an oncology pharmacy practice model focusing on accountability for optimal drug therapy according to the pharmaceutical care model. The resident will also be prepared for board certification in oncology pharmacy upon completion of this residency.
The University of Arizona Cancer Center is one of 45 comprehensive cancer centers in the country and is the only institution in Arizona designated by the National Cancer Institute as a Comprehensive Cancer Center. The Cancer Center focuses on patient care as well as basic and clinical research, prevention, education, outreach, and training. The residency program emphasizes clinical practice consisting of core (required) and elective learning experiences in acute and ambulatory oncology pharmacy practice. These core and elective learning experiences will provide the basic foundation for quality clinical practice. In addition, this program enables the resident to learn and apply teaching and research techniques.
The resident will participate in safe, evidence-based, compassionate, and cost-effective patient care for oncology patients in the acute and ambulatory setting. All patient care activities are under the supervision of attending pharmacists and commensurate with the resident’s level of training as determined by the residency program. The resident will communicate effectively with supervising preceptors regarding his/her patient evaluation, interpretation of diagnostic tests, and plan of care and intended therapeutic interventions. Additionally, the resident will provide oral and written consultations focused on improving patient outcomes and enhancing communication with the healthcare team.
If the resident did not complete a teaching certificate during their PGY1 residency training, he/she is required to participate in the longitudinal Teaching Certificate (PRSTL) Program by The University of Arizona College of Pharmacy, known as Pharmacy Resident Scholars in Teaching and Learning (PRSTL). As part of the PRSTL program, the resident’s responsibilities include the following: assisting in the education and training of pharmacy students during IPPE and APPE rotations, participating in clinical faculty research as opportunities become available, and facilitating patient case and journal club discussions.
The resident is also responsible for the development, implementation, and evaluation of a research project. The objective is to develop the resident's skills in problem identification, investigation, and solution. Each project must be approved by the residency program director. The results will be presented at the Hematology/Oncology Pharmacist Association (HOPA) Annual Conference, as well as additional professional meetings per resident and program director discretion. After completion of data collection and analysis, the resident will be responsible for drafting a manuscript suitable for publication in a peer-reviewed journal.
The resident is responsible for an operational staffing shift one weekend per month at the outpatient infusion center, and participating in a rotating inpatient operational staffing position with other pharmacy residents on weeknights. Operational staffing will include performing centralized pharmacy order verification, answering drug information questions, and other duties as deemed necessary.
The salary for this program is competitive with similar residency programs nationwide. The resident is entitled to all benefits provided to full-time University of Arizona appointed personnel. Funds may be provided to help offset travel expenses to selected state and national meetings.
The University of Arizona Oncology Residency Program does not participate in the ASHP-Associated Pharmacy Online Residency Centralized Application Service (PhORCAS) or the National Matching Service (NMS) at this time.
Please submit the following REQUIRED documents via email to Dr. McBride at Ali.McBride@bannerhealth.com by JANUARY 15th, 2018:
- Letter of Intent
- Pharmacy School Transcripts
- Three (3) Letters of Recommendation
- Curriculum Vitae
On-site interview for invited applicants will occur in late January through February.
For additional information about the PGY2 Oncology Pharmacy Residency Program, please contact:
Ali McBride, PharmD, MS, BCOP, FAzPA
Director, PGY2 Oncology Pharmacy Residency Program
University of Arizona Cancer Center
3838 N. Campbell Ave.
Tucson, AZ 85719
Phone: (520) 694-0398